Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA ...

President Donald Trump on Tuesday used his State of the Union address to criticize a Maryland juvenile court case involving a ...

BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy ...

BGE says storm center is mobilized for winter weather in Maryland on Sunday ...

Hearst today named David Delaney, MD, president of its Hearst Health portfolio company FDB (First Databank, Inc.), the ...

Saturday marks the midpoint of Maryland’s 2026 legislative session, a 90-day sprint that has already been defined by fast-tracked immigration legislation, a stalled redistricting push, ...

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced ...

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared ...

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.